BioAdvance
  • Home
  • About
  • Team
  • Portfolio
  • News
  • FAQ
  • Contact


News

Jul 17, 2023

By bioadvance


Mar 01, 2023

By bioadvance


Dec 14, 2022

By bioadvance


Aug 15, 2022

By bioadvance


Jul 13, 2022

By bioadvance


Jul 07, 2022

By bioadvance


Apr 05, 2022

By bioadvance


Mar 30, 2022

By bioadvance


Mar 15, 2022

By bioadvance


Feb 18, 2022

By bioadvance


  • ← Older posts

Current News

  • ImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS-001 in Relapsed or Refractory Advanced Solid Tumors
  • SIRPant Immunotherapeutics to Present Trial in Progress Poster at the Society for Immunotherapy of Cancer 38th Annual Meeting
  • Venatorx Pharmaceuticals to Present at IDWeek 2023
  • Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze
  • Relmada Therapeutics Announces Efficacy and Safety Results from the Phase 3 LongTerm Study of REL-1017 in Major Depressive Disorder

© 2013-2023 BioAdvance. All rights reserved.